湖南慧泽生物医药科技有限公司（简称 慧泽医药 ）成立于2014年，是一家专注于创新制剂研发及早期临床试验专业服务的合同研究组织（CRO）。
Hunan Huize Biopharma S&T Co., Ltd. (referred to as "Huize Biopharma") was founded in 2014, It is a contract research organization (CRO) specializing in development of innovative formulations and professional services for early clinical trials.
慧泽医药总部位于长沙高新区五矿·麓谷科技产业园，旗下设有专注于生物样本分析服务的湖南泰新医药科技有限公司、专注于数据管理与统计分析及受试者管理服务的湖南慧铃数字科技有限公司、专注于SMO服务的湖南科迪特医药科技有限公司、专注于特殊医学食品研发的湖南慧泽特医食品有限公司共四个子公司。
HUIZE Biopharma Headquarters located in the Minmetals - Lugu Science and Technology Industrial Park in Changsha High-tech Zone, We have four subsidiaries as Hunan TAIXIN Pharmaceutical Technology Co., Ltd., which focuses Ｏn biological sample analysis services; Hunan HUILING Digital Technology Co., Ltd., which focuses Ｏn data management, statistical analysis and subject management services; Hunan KEDITE Medical Technology Co., Ltd., which focuses Ｏn SMO services; and Hunan HUIZE Special Medical Food Co., Ltd., which focuses Ｏn the research and development of special medical foods.
慧泽医药与包括湘雅医院在内的多家医院联合建设临床试验专业，与中南大学联合建设有药物制剂优化与早期临床评价工程技术研究中心、生物药剂学与药物动力学研究中心、外用制剂临床评价中心、药物经济学评价中心等。公司有近两百人的专业服务团队，与国内外近百家药企及药学研究单位建立了长期、友好的战略合作伙伴关系。完成技术服务项目包括创新药I期临床试验和仿制药PK/BE 试验总计超过500项。经验丰富、技术实力雄厚，质量体系覆盖全部临床机构、分析测试中心、SMO公司及数据管理统计分析单位，确保全过程服务符合ICH-GCP规范要求。
HUIZE Biopharma and many hospitals, including XiangYa Hospital, have jointly established a clinical trial specialty. HUIZE Biopharma has also worked with Central South University to jointly build a pharmaceutical preparation optimization and early clinical evaluation engineering technology research center, a biological pharmacy and pharmacokinetic research center, an external preparation clinical evaluation center, a pharmacoeconomic evaluation center, etc. The company has a professional service team of nearly 200 people, and has established long-term and friendly strategic partnerships with nearly a hundred pharmaceutical enterprises and pharmaceutical research institutes at home and abroad. HUIZE has completed more than 500 technical service projects, including the Phase I of clinical trials of innovative drugs and the PK/BE test of generic drugs. With rich experience and strong technical strength, the quality system covers all clinical institutions, analysis and testing centers, SMO companies and data management and statistical analysis units, to ensure that the whole process of service in accordance with the requirements of ICH-GCP specifications.
